Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (5,436) Arrow Down
Filter Results: (5,436) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (5,436)
    • People  (16)
    • News  (2,045)
    • Research  (2,750)
    • Events  (8)
    • Multimedia  (223)
  • Faculty Publications  (1,953)

Show Results For

  • All HBS Web  (5,436)
    • People  (16)
    • News  (2,045)
    • Research  (2,750)
    • Events  (8)
    • Multimedia  (223)
  • Faculty Publications  (1,953)
← Page 128 of 5,436 Results →
  • February 2009
  • Case

Avid Radiopharmaceuticals: The Venture Debt Question

By: Matthew Rhodes-Kropf and Ann Leamon
The CEO of a promising biotech company must decide how to respond to the macro-economic slump of late 2008. He had planned to pursue an aggressive schedule, moving the firm's Alzheimer's and Parkinson's disease imaging compounds through clinical trials and into the... View Details
Keywords: Financial Crisis; Entrepreneurship; Borrowing and Debt; Venture Capital; Financial Management; Investment; Health Testing and Trials; Expansion; Biotechnology Industry; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Rhodes-Kropf, Matthew, and Ann Leamon. "Avid Radiopharmaceuticals: The Venture Debt Question." Harvard Business School Case 809-086, February 2009.
  • Web

All Industries

Employment Data All Industries Employment Data All Industries All Industries Select an Industry to Access Additional Detail Pages: All Industries All Industries Consulting Consumer Products Entertainment / Media Health View Details
  • 26 Jul 2016
  • Working Paper Summaries

The Impact of the Entry of Biosimilars: Evidence from Europe

Keywords: by Fiona Scott Morton, Ariel Dora Stern, and Scott Stern; Health; Health; Health
  • July 2019
  • Article

The Impact of Price Regulation on the Availability of New Drugs in Germany

By: Ariel Dora Stern, Felicitas Pietrulla, Annika Herr, Aaron S. Kesselheim and Ameet Sarpatwari
The 2011 German Pharmaceutical Market Restructuring Act (“AMNOG”) subjected branded, non-rare disease drugs to price regulation based on an assessment of their clinical benefit. Assessment outcomes range from “major added benefit” to “less benefit than the appropriate... View Details
Keywords: Regulation; Pharmaceuticals; Healthcare; Health Care and Treatment; Price; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; Germany
Citation
Find at Harvard
Read Now
Related
Stern, Ariel Dora, Felicitas Pietrulla, Annika Herr, Aaron S. Kesselheim, and Ameet Sarpatwari. "The Impact of Price Regulation on the Availability of New Drugs in Germany." Health Affairs 38, no. 7 (July 2019): 1182–1187.
  • Web

Cases & Teaching Notes - Institute For Strategy And Competitiveness

Collection Partners In Health: Costing Primary Care in Haiti by Robert S. Kaplan and Mahek A. Shah Partners in Health, a global NGO focused on delivering health View Details
  • 24 Feb 2022
  • News

Want to Prevent the Next Hospital Bed Crisis? Enlist the SEC

  • March 2024
  • Article

Medicare Price Negotiation and Pharmaceutical Innovation Following the Inflation Reduction Act

By: Matthew Vogel, Pragya Kakani, Amitabh Chandra and Rena M. Conti
The Inflation Reduction Act (IRA) requires Medicare to negotiate lower prices for some medicines with high Medicare spending. Using historical data from public and proprietary sources to apply the IRA's negotiation criteria retrospectively, we identify all drugs that... View Details
Keywords: Policy; Government Legislation; Health Care and Treatment; Negotiation; Price; Pharmaceutical Industry
Citation
Find at Harvard
Purchase
Related
Vogel, Matthew, Pragya Kakani, Amitabh Chandra, and Rena M. Conti. "Medicare Price Negotiation and Pharmaceutical Innovation Following the Inflation Reduction Act." Nature Biotechnology 42, no. 3 (March 2024): 406–412.
  • Web

Entrepreneurship - Recruiting

Salary $160,000 Industries Consumer Products 3% Entertainment / Media 3% Financial Services 7% Health Care 17% Manufacturing 8% Nonprofit / Government 2% Retail 2% Services 3% Technology 55% Functions... View Details
  • Web

Human Behavior & Decision-Making - Faculty & Research

Transforming Care Delivery & Payment By: Robert S. Kaplan , David N. Bernstein and Mary L. Witkowski May 2025 | Case | Faculty Research Health care in the U.S. and globally... View Details

    Emily R. McComb

    Emily McComb is a Senior Lecturer in the Finance Unit at HBS, teaching "Finance 2" in the required curriculum of the MBA program, as well as a co-leader of the HBS Impact Investment Fund in the elective curriculum. Prior to joining the HBS faculty in 2017, Emily was... View Details

    Keywords: health care; health care
    • 22 Feb 2024
    • News

    Combat-Tested Cancer Coaching

    nearby Borders bookstore revealed a three-year life expectancy with no available treatment options. And trying to navigate the complexities of the American health care system—bouncing from pathologist to a... View Details
    • 14 Feb 2023
    • HBS Case

    Is Sweden Still 'Sweden'? A Liberal Utopia Grapples with an Identity Crisis

    Sweden has long seemed like a social-welfare capitalist dream come true, where companies and labor unions collaborate in harmony with government support. Swedish citizens are among the wealthiest in the world, and they enjoy publicly provided View Details
    Keywords: by Lane Lambert

      Debora L. Spar

      Debora Spar is the Jaime and Josefina Chua Tiampo Professor of Business Administration at Harvard Business School and Senior Associate Dean for Business and Global Society. Her current research focuses on issues of gender and technology, and the interplay between... View Details

      Keywords: health care; health care; health care; health care; health care; health care; health care; health care; health care; health care
      • January 2021
      • Article

      State and Local Government Employment in the COVID-19 Crisis

      By: Daniel Green and Erik Loualiche
      Local governments are facing large losses in revenues and increased expenditures because of the COVID-19 crisis. We document a causal relationship between fiscal pressures induced by COVID-19 and the layoffs of state and local government workers. States that depend... View Details
      Keywords: Local Government; Municipal Finance; Public Finance; Fiscal Capacity; Fiscal Policy; Governance; Local Range; Health Pandemics; Employment; Finance; Policy; Public Sector
      Citation
      Read Now
      Related
      Green, Daniel, and Erik Loualiche. "State and Local Government Employment in the COVID-19 Crisis." Art. 104321. Journal of Public Economics 193 (January 2021).
      • Web

      Technology & Operations Management Curriculum - Faculty & Research

      Operations Antonio Moreno Spring 2026 Q4 1.5 Driving Profitable Growth (also listed under Strategy) Juan Alcacer , Raffaella Sadun Fall 2025 Q2 1.5 Field Course: Advanced Business Plans for Innovating in Health View Details
      • Web

      Impact Stories - Impact Stories

      Play 06 Feb 2025 LDIvideo U.S. Health Care Cost Growth: Up or Down? Re: Amitabh Chandra Play Improving Health Care... View Details
      • 05 May 2022
      • Research & Ideas

      Why Companies Raise Their Prices: Because They Can

      much as they did." Instead, markups—the difference between prices charged at checkout and the marginal costs incurred by a company in order to make a product—climbed about 25 percent between 2006 and 2019, according to research by... View Details
      Keywords: by Rachel Layne
      • May 2024
      • Supplement

      DRSi (A)

      By: Richard S. Ruback and Royce Yudkoff
      In March of 2019, Jen Ransom Fuller purchased DRSi. DRSi, located in Bellevue, Washington, printed and reproduced architectural plans and drawings. Fuller planned to use her first year of ownership to learn the business and to run it in much the same way as the seller.... View Details
      Keywords: Acquisition; Small Business; Cost vs Benefits; Decisions; Business Education; Corporate Entrepreneurship; Leadership Style; Leading Change; Business or Company Management; Problems and Challenges; Health Pandemics; Selection and Staffing; Employee Relationship Management; Production; Logistics; Safety; United States; Washington (state, US)
      Citation
      Purchase
      Related
      Ruback, Richard S., and Royce Yudkoff. " DRSi (A)." Harvard Business School Multimedia/Video Supplement 224-717, May 2024.

        Nitin Nohria

        Nitin Nohria served as the tenth dean of Harvard Business School from 2010-2020. He previously served as co-chair of the Leadership Initiative, Senior Associate Dean of Faculty Development, and Head of the Organizational Behavior unit.

        As Dean, building on... View Details

        Keywords: health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care; health care
        • October 2010 (Revised November 2010)
        • Background Note

        Plavix: Drugs in the Age of Personalized Medicine

        By: Richard G. Hamermesh, Mara G. Aspinall and Rachel Gordon
        PIavix, one of the world's best selling drugs in 2010, appears to have a limited future. Its patent was due to expire soon, and recently new data had been discovered that indicated that a small subset of the population would be at risk for stroke, heart attack, or even... View Details
        Keywords: Health Care and Treatment; Product Positioning; Business and Government Relations; Genetics; Competitive Strategy; Pharmaceutical Industry
        Citation
        Educators
        Purchase
        Related
        Hamermesh, Richard G., Mara G. Aspinall, and Rachel Gordon. "Plavix: Drugs in the Age of Personalized Medicine." Harvard Business School Background Note 811-001, October 2010. (Revised November 2010.)
        • ←
        • 128
        • 129
        • …
        • 271
        • 272
        • →
        ǁ
        Campus Map
        Harvard Business School
        Soldiers Field
        Boston, MA 02163
        →Map & Directions
        →More Contact Information
        • Make a Gift
        • Site Map
        • Jobs
        • Harvard University
        • Trademarks
        • Policies
        • Accessibility
        • Digital Accessibility
        Copyright © President & Fellows of Harvard College.